Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono"), today announced that the results from the open label Phase 2 PROSPECT Study of tirabrutinib is to be ...

The abnormal signal demarcation exhibits a distinct boundary at the tumor interface, while demonstrating a gradual, indistinct transition toward the adjacent brain parenchyma. Histopathological ...

Someone with a brain tumor can experience the following symptoms: Persistent headaches, seizures, cognitive or speech ...

A new model suggests that astrocytes might be used in computation, coordinating with neurons and connecting synapses in ...

Massachusetts health officials have completed an inspection of Newton-Wellesley Hospital after concerns arose about cancer in some of the facility's nurses.

In the largest ever study of its kind, an analysis of entire tumor genomes has provided the most complete picture yet of an ...

The MRI image shows a brain tumor in an inauspicious location, – and a brain biopsy will entail high risks for the patient, ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

Brain tumors remain among the most challenging conditions in modern medicine. Due to their complexity and location, many of them are difficult to access, even with the most advanced surgical and ...

The diagnosis of a brain tumor delivers a profound shock, instantly transforming life for patients and their loved ones. Despite medical advances, these complex growths within the most essential ...

Another former nurse at Newton-Wellesley Hospital has reportedly been diagnosed with a brain tumor, the hospital has confirmed. This seventh reported tumor case on the fifth floor maternity wing ...

May 1, 2025 — Researchers detail their discoveries about why the brain tumor glioblastoma is so aggressive. Their findings center on ZIP4, a protein that transports zinc throughout the body and ...